These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 23442996)
1. NSW annual report describing adverse events following immunisation, 2011. Mahajan D; Reid S; Cook J; Macartney K; Menzies RI N S W Public Health Bull; 2012 Dec; 23(9-10):187-200. PubMed ID: 23442996 [TBL] [Abstract][Full Text] [Related]
2. Annual report: Surveillance of adverse events following immunisation in Australia, 2011. Mahajan D; Cook J; Dey A; Macartney K; Menzies RI Commun Dis Intell Q Rep; 2012 Dec; 36(4):E315-32. PubMed ID: 23330706 [TBL] [Abstract][Full Text] [Related]
3. NSW annual report describing adverse events following immunisation, 2010. Mahajan D; Campbell-Lloyd S; Cook J; Menzies RI N S W Public Health Bull; 2011 Nov; 22(9-10):196-208. PubMed ID: 22060057 [TBL] [Abstract][Full Text] [Related]
4. Annual report: surveillance of adverse events following immunisation in Australia, 2008. Menzies R; Mahajan D; Gold MS; Roomiani I; McIntyre P; Lawrence G Commun Dis Intell Q Rep; 2009 Dec; 33(4):365-81. PubMed ID: 20301966 [TBL] [Abstract][Full Text] [Related]
5. Annual report: Surveillance of adverse events following immunisation in Australia, 2005. Lawrence G; Boyd I; McIntyre P; Isaacs D Commun Dis Intell Q Rep; 2006; 30(3):319-33. PubMed ID: 17120485 [TBL] [Abstract][Full Text] [Related]
6. Surveillance of adverse events following immunisation: Australia, 2000-2002. Lawrence G; Menzies R; Burgess M; McIntyre P; Wood N; Boyd I; Purcell P; Isaacs D Commun Dis Intell Q Rep; 2003; 27(3):307-23. PubMed ID: 14510057 [TBL] [Abstract][Full Text] [Related]
7. Annual report: surveillance of adverse events following immunisation in Australia, 2009. Mahajan D; Roomiani I; Gold MS; Lawrence GL; McIntyre PB; Menzies RI Commun Dis Intell Q Rep; 2010 Sep; 34(3):259-76. PubMed ID: 21090181 [TBL] [Abstract][Full Text] [Related]
8. Annual report: surveillance of adverse events following immunisation in Australia, 2007. Lawrence G; Gold MS; Hill R; Deeks S; Glasswell A; McIntyre PB Commun Dis Intell Q Rep; 2008 Dec; 32(4):371-87. PubMed ID: 19374268 [TBL] [Abstract][Full Text] [Related]
9. Simultaneous vaccination of Chinese applicants for a United States immigrant visa. Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068 [TBL] [Abstract][Full Text] [Related]
10. Surveillance of adverse events following immunisation: Australia 2002 to 2003. Lawrence G; Boyd I; McIntyre P; Isaacs D Commun Dis Intell Q Rep; 2004; 28(3):324-38. PubMed ID: 15574056 [TBL] [Abstract][Full Text] [Related]
11. Annual report: surveillance of adverse events following immunisation in Australia, 2010. Mahajan D; Cook J; McIntyre PB; Macartney K; Menzies RI Commun Dis Intell Q Rep; 2011 Dec; 35(4):263-80. PubMed ID: 22624487 [TBL] [Abstract][Full Text] [Related]
12. Annual report on surveillance of adverse events following immunisation in Australia, 2006. Lawrence GL; Aratchige PE; Boyd I; McIntyre PB; Gold MS Commun Dis Intell Q Rep; 2007 Sep; 31(3):269-82. PubMed ID: 17974219 [TBL] [Abstract][Full Text] [Related]
13. Annual report: surveillance of adverse events following immunisation in Australia, 2004. Lawrence GL; Boyd I; McIntyre PB; Isaacs D Commun Dis Intell Q Rep; 2005; 29(3):248-62. PubMed ID: 16220860 [TBL] [Abstract][Full Text] [Related]
14. Surveillance of adverse events following immunisation in Australia, 2012. Mahajan D; Dey A; Cook J; Harvey B; Menzies RI; Macartney KM Commun Dis Intell Q Rep; 2014 Sep; 38(3):E232-46. PubMed ID: 25391415 [TBL] [Abstract][Full Text] [Related]
15. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization. Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the tolerability of an acellular pertussis-containing vaccine given as the fifth booster dose in differently primed children. Kemmeren JM; Timmer SS; van der Maas NA; de Melker HE Vaccine; 2011 Jun; 29(26):4373-7. PubMed ID: 21514347 [TBL] [Abstract][Full Text] [Related]
18. Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. Daley MF; Yih WK; Glanz JM; Hambidge SJ; Narwaney KJ; Yin R; Li L; Nelson JC; Nordin JD; Klein NP; Jacobsen SJ; Weintraub E Vaccine; 2014 May; 32(25):3019-24. PubMed ID: 24699471 [TBL] [Abstract][Full Text] [Related]
19. NSW annual immunisation coverage report, 2010. Hull B; Dey A; Campbell-Lloyd S; Menzies RI; McIntyre PB N S W Public Health Bull; 2011 Nov; 22(9-10):179-95. PubMed ID: 22060056 [TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine. Pichichero ME; Bernstein H; Blatter MM; Schuerman L; Cheuvart B; Holmes SJ; J Pediatr; 2007 Jul; 151(1):43-9, 49.e1-2. PubMed ID: 17586189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]